SARS-CoV-2 hybrid immunity CDR profiling

downstream-application

SARS-CoV-2 hybrid immunity CDR profiling: downstream-application. LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from…

LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from vaccination-only ones.

Kind	downstream-application
Deep learning	no
Acquisition	DDA
Application area	Antibodyomics

Data

What the papers describing this method trained it on and reported its results on, as each paper states it. A version is named only where the paper names one.

Deposited

• Complementarity Determining Regions in SARS-CoV-2 hybrid immunity (as deposited)

Paper describing it

• Complementarity determining regions in SARS-CoV-2 hybrid immunity (2023, Frontiers in Immunology, peer-reviewed)

Authors (17)

Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Lise Boon, Wim Maes, Nico Callewaert, Bas Calcoen, Lina Ancheva, Maaike Cockx, Nick Geukens, Kusay Arat, Rita Derua, Pieter Vermeersch, Sebastien Carpentier, Xavier Bossuyt

Seen in the charts

• Application areas
• Models and the authors behind them

Back to the full map